Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Scheme 1 | Alzheimer's Research & Therapy

Scheme 1

From: Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mousmodel of Alzheimer’s disease

Scheme 1

Schematic illustration of the mechanism by Photobiomodulation (PBM) improve Alzheimer’s disease (AD) pathology. PBM enhances mitochondrial respiratory by photoreceptor cytochrome c oxidase (CCO), which promotes the production of Adenosine Triphosphate (ATP); inhibites neuronal apoptosis by regulating mitochondrial energy metabolism; regulates microglial polarization and autophagy, promoting Aβ clearance, reducing neurological damage. Ultimately, improving cognitive impairment in AD. Scheme1 was created by Figdraw

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193